Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders
Rajib Paul, Joyobrato Nath, Satinath Paul, et al.
Neurochemistry International (2021) Vol. 148, pp. 105068-105068
Closed Access | Times Cited: 21

Showing 21 citing articles:

Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 11
The potential neuroprotective effects of stingless bee honey
Nurdarina Ausi Zulkifli, Zurina Hassan, Mohd Zulkifli Mustafa, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 14
7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development
Guoqi Zhu, Shaojie Yang
Current Neuropharmacology (2021) Vol. 20, Iss. 8, pp. 1479-1497
Open Access | Times Cited: 31
Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways
Banashree Chetia Phukan, Rubina Roy, Indira Gahatraj, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5657-5699
Open Access | Times Cited: 11
Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage
Selena Gonzalez, Tyne L.M. McHugh, Tao Yang, et al.
Neurobiology of Disease (2021) Vol. 162, pp. 105563-105563
Open Access | Times Cited: 24
A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development
Jingyun Wu, Luisa Möhle, Thomas Brüning, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14763-14763
Open Access | Times Cited: 18
Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases
Jinping Liang, Yuchen Zhu, Shasha Liu, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 2
Small-molecule 7,8-dihydroxyflavone counteracts compensated and decompensated cardiac hypertrophy via AMPK activation.
Pengzhou Hang, Peifeng Li, Jie Liu, et al.
PubMed (2022) Vol. 19, Iss. 11, pp. 853-866
Closed Access | Times Cited: 11
Can Brain-derived Neurotrophic Factor (BDNF) Mimetics be a Way Out for Neurodegenerative Diseases?
Orhan Tansel Korkmaz
Current Pharmaceutical Design (2023) Vol. 29, Iss. 4, pp. 246-250
Closed Access | Times Cited: 6
The regulatory role of the BDNF/TrkB pathway in organ and tissue fibrosis.
Pengzhou Hang, Feng-Qin Ge, Peifeng Li, et al.
PubMed (2021) Vol. 36, Iss. 11, pp. 1133-1143
Closed Access | Times Cited: 14
Impact of dietary plant flavonoids on 7,8‐dihydroxyflavone transepithelial transport in human intestinal Caco‐2 cells
Yufeng Chen, Guobin Xia, Chunfeng Wang, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 11, pp. 6888-6898
Open Access | Times Cited: 5
The role of pristine carbon nanotubes as nanocarriers of 7,8-dihydroxyflavone
Cecilia Espíndola, Ana Gómez-Méndez, Marı́a Luisa Moyá, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106068-106068
Open Access | Times Cited: 1
Neuro-nutraceuticals: Natural products nourish the brain but be aware of contrary effects
Robert J. Williams, Kochupurackal P. Mohanakumar, Philip M. Beart
Neurochemistry International (2021) Vol. 150, pp. 105159-105159
Closed Access | Times Cited: 8
MSK1 is required for the beneficial synaptic and cognitive effects of enriched experience across the lifespan
Lorenzo Morè, Lucia Privitera, Daniel D. Cooper, et al.
Aging (2023) Vol. 15, Iss. 13, pp. 6031-6072
Open Access | Times Cited: 3
Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology
Rubina Roy, Rajib Paul, Pallab Bhattacharya, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 16, pp. 2830-2848
Closed Access | Times Cited: 3
Targeting the Pathological Hallmarks of Alzheimer’s Disease Through Nanovesicleaided Drug Delivery Approach
Rubina Roy, Pallab Bhattacharya, Anupom Borah
Current Drug Metabolism (2022) Vol. 23, Iss. 9, pp. 693-707
Closed Access | Times Cited: 5
Nutraceuticals and bioactive components of herbal extract in the treatment and prevention of neurological disorders
Chandana Choudhury Barua, Daisy Sharma, P. Devi, et al.
Elsevier eBooks (2023), pp. 577-600
Closed Access | Times Cited: 2
Induction of Apoptosis by 7,8-Dihydroxyflavone, a Plant Flavonoid, in Human Hepatocellular Carcinoma HepG2 Cells
Hyun Hwangbo, Yung Hyun Choi
Journal of the Korean Society of Food Science and Nutrition (2024) Vol. 53, Iss. 10, pp. 1021-1029
Open Access

Tarang Varshney, Shaily Saini
International Journal of Pharmaceutical Sciences and Research (2023) Vol. 14, Iss. 7
Open Access
Síntese e avaliação biológica de novas aminoflavonas planejadas como potenciais anticolinesterásicos para o tratamento da Doença de Alzheimer
Karinne Esteves Prado
(2022)
Open Access

Shreya Shreshtha, Rahul Kumar Verma, T.S. Gopenath, et al.
International Journal of Pharmaceutical Sciences and Research (2022) Vol. 13, Iss. 11
Open Access
Page 1

Scroll to top